MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Apathy"

  • MDS Virtual Congress 2020

    Apathy as a non-motor symptom(NMS) in patients with Parkinson’s disease(PwPD) and patients with Huntington’s disease(PwHD) in Tomsk, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Center, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate and compare the apathy profile in PwHD and PwPD, using the same clinical criteria to assess the severity of…
  • MDS Virtual Congress 2020

    MOve To ImprovE physical activity in Parkinson’s disease (MOTIvatE): A pilot randomized clinical trial of gamification

    N. Dahodwala, M. Engeland, W. Kerr, L. Walsh, M. Patel (Philadelphia, PA, USA)

    Objective: To test the feasibility and impact of a behaviorally designed gamification intervention to improve goal-directed behavior assessed by physical activity levels in Parkinson’s disease…
  • MDS Virtual Congress 2020

    Quality of Life Study of Patients Living with Parkinson’s Disesae in Sub-Saharan Africa

    M. Fall, T.M Sarr (Dakar, Senegal)

    Objective: The objective is to assess the quality of life of patients with Parkinson's disease followed in Senegal. Background: Parkinson's disease is a neurodegenerative disease,…
  • 2019 International Congress

    Progression of dopaminergic and serotonergic dysfunction related to motor and nonmotor manifestations in apathetic and non-apathetic parkinsonian patients: a 4-year longitudinal double-tracer PET study

    S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

    Objective: To investigate the progression of dopaminergic and serotonergic dysfunction and their relation to motor and nonmotor impairment in parkinsonian patients with or without apathy,…
  • 2019 International Congress

    Predictive Factors for Depression in a Multicentric Parkinson’s Disease Mexican Cohort

    A. Banegas-Lagos, A. Cervantes-Arriaga, D. Garza-Brambila, E. Garcia-Berlanga, K. Salinas-Barboza, S. Isais-Millan, A. Anaya-Escamilla, E. Velazquez-Avila, G. Parra, A. Gonzalez-Cantú, M. Rodriguez-Violante, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To identify predictive factors for depression in a multicentric Parkinson’s disease (PD) mexican cohort. Background: Depression is a common symptom of PD with a…
  • 2019 International Congress

    Prevalence and risk factors for impulsive compulsive behaviors in a cohort of Parkinson’s disease patients

    S. Simoni, N. Tambasco, P. Eusebi, P. Nigro, E. Brahimi, F. Paolini Paoletti, M. Filidei, G. Cappelletti, P. Calabresi (Perugia, Italy)

    Objective: Objective of the study was to analyze the risk factors for the development of these behaviors. Background: Impulsive compulsive behaviors (ICBs) are a frequent…
  • 2019 International Congress

    Apathy : Clinical Correlates in Parkinson’s disease Psychosis

    YM. Wan, D. van Wamelen, V. Leta, D. Trivedi, A. Podlewska, TS. Lee, EK. Tan, D. Aarsland, K. Chaudhuri (London, United Kingdom)

    Objective: To determine the frequency and clinical correlates of apathy in Parkinson’s disease (PD) psychosis. Background: The underlying pathology of apathy in PD psychosis, itself…
  • 2019 International Congress

    Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia

    B. Muñoz, J. Valderrama, L. Botero, J. Orozco (Cali, Colombia)

    Objective: To describe and correlate the apathy and cognitive profile of patients with Parkinson’s disease (PD). Background: Prevalence of apathy in PD is highly variable…
  • 2019 International Congress

    The effect of istradefylline on mood disorders in Parkinson’s disease

    H. Nagayama, O. Kano, H. Murakami, M. Hamada, R. Sengoku, Y. Shim, T. Toda (Tokyo, Japan)

    Objective: The effectiveness of istradefylline for treatment of mood disorders in patients with Parkinson's disease (PD) was examined in an open-label trial. Background: Depression is…
  • 2019 International Congress

    Higher levels of physical activity is associated with fewer non-motor symptoms in early Parkinson’s disease: a 1-year follow-up study

    S. Ng, N. Chia, M. Abbas, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: To examine the physical activity (PA) level in early Parkinson’s disease (PD) patients and its association with non-motor symptoms (NMS). Background: Lower PA is…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 10
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley